Matches in Nanopublications for { ?s ?p "[In addition, immunohistochemical studies on mouse tumors injected with cisplatin or paclitaxel treated residual cells displayed higher staining for the proliferative antigen Ki67, oncogeneic CA125, epithelial E-cadherin as well as cancer stem cell markers such as Oct4 and CD117, compared to mice injected with control untreated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP635860.RAS44td3B6f6xD8L5xy9CRKb8fYbXAshPMS15eBFQ6xxc130_assertion description "[In addition, immunohistochemical studies on mouse tumors injected with cisplatin or paclitaxel treated residual cells displayed higher staining for the proliferative antigen Ki67, oncogeneic CA125, epithelial E-cadherin as well as cancer stem cell markers such as Oct4 and CD117, compared to mice injected with control untreated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635860.RAS44td3B6f6xD8L5xy9CRKb8fYbXAshPMS15eBFQ6xxc130_provenance.
- NP636144.RAbJtJebePaMdCslprMeRhM_PiJOWPVJ11pMY_apWWPbk130_assertion description "[In addition, immunohistochemical studies on mouse tumors injected with cisplatin or paclitaxel treated residual cells displayed higher staining for the proliferative antigen Ki67, oncogeneic CA125, epithelial E-cadherin as well as cancer stem cell markers such as Oct4 and CD117, compared to mice injected with control untreated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636144.RAbJtJebePaMdCslprMeRhM_PiJOWPVJ11pMY_apWWPbk130_provenance.
- NP525165.RAFELhBjb8DF9KRk1C6EGrhcExjuY3CgVWnNWEayHuB_g130_assertion description "[In addition, immunohistochemical studies on mouse tumors injected with cisplatin or paclitaxel treated residual cells displayed higher staining for the proliferative antigen Ki67, oncogeneic CA125, epithelial E-cadherin as well as cancer stem cell markers such as Oct4 and CD117, compared to mice injected with control untreated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525165.RAFELhBjb8DF9KRk1C6EGrhcExjuY3CgVWnNWEayHuB_g130_provenance.
- NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_assertion description "[In addition, immunohistochemical studies on mouse tumors injected with cisplatin or paclitaxel treated residual cells displayed higher staining for the proliferative antigen Ki67, oncogeneic CA125, epithelial E-cadherin as well as cancer stem cell markers such as Oct4 and CD117, compared to mice injected with control untreated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.